Brind.

Automated Insights generated a story using company data related to BioMarin Pharmaceutical on August 5, 2025.

1 report, 1 independent Updated Aug 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Automated Insights BioMarin Pharmaceutical

Keep exploring

The entities involved

Automated Insights
company
- Zacks provided analyst estimates for Cognizant's earnings, which Automated Insights then used to generate a story.Sun 09:21
- Automated Insights reported that AES is based in Arlington and shares performance metrics compared to the S&P 500.Sun 09:11
BioMarin Pharmaceutical
American company
- Investors are comparing the financial performance metrics of BioMarin Pharmaceutical and Metagenomi.Sun 20:41

Related events

MarketBeat aggregated analyst recommendations and price targets for BioMarin Pharmaceutical and Abeona Therapeutics Inc.Sep 4
Applied DNA Sciences and BioMarin Pharmaceutical are identified as competing companies within the healthcare market.Sep 3

Coverage

Newest first; wire copies grouped

Aug 5Associated Press FinanceBioMarin: Q2 Earnings Snapshot SAN RAFAEL, Calif. (AP) — SAN RAFAEL, Calif. (AP) — BioMarin Pharmaceutical Inc. (BMRN) on Monday reported second-quarter profit of $240.5 million. The San Rafael, Cali